Early-life mitochondrial DNA mutations drive age-related pathology in mice
Manipulating mitochondrial fusion can alter tissue-specific selection against deleterious variants that arise early in development.
bioRxiv · Shemtov SJ et al. · Paper published 27 Sep 2026
In a new preprint, researchers engineered mice to confine mitochondrial DNA mutagenesis to specific developmental windows. The authors found that mitochondrial mutations acquired during the first two months of life were sufficient to trigger diverse age-related pathologies later in adulthood. The severity of these diseases depended on distinct, tissue-specific selective pressures that determined which mutations persisted or expanded over time. Furthermore, the team demonstrated that altering mitochondrial fusion, both in vitro and in vivo, modified the selection against these harmful genetic variants. These findings show that early-life mutational events can establish the trajectory of tissue aging in mice, while mitochondrial dynamics can directly influence the survival of pathogenic variants.
Why it matters
The work indicates that the trajectory of aging may be set by mutational events early in life. Modulating mitochondrial dynamics may offer a therapeutic path to limit the expansion of pathogenic variants before decline occurs.
Caveats
This study is an unreviewed preprint conducted in mice and cell culture. Further research is necessary to confirm whether human tissues exhibit similar early-life mutational dynamics and selective pressures.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age
Shemtov SJ, Hwang E, Chung CS et al.
bioRxiv · 27 Sep 2026 · Preprint, not yet peer-reviewed
- Relevance
- Core geroscience
- News value
- Important
- Evidence
- Animals
- Status
- Preprint
More on Mitochondria
See allCardiolipin loss drives muscle fiber shifts during aging via a nuclear receptor
Restoring cardiolipin synthesis in knockout mice reversed muscle atrophy and prevented premature death.
Nature aging · Finger F et al.
Inhibiting miR-128-3p restores muscle mass and function in aged mice
The microRNA inhibitor also improved cardiac outcomes after infarction and reduced pathology in mouse and pig models of muscular dystrophy.
bioRxiv : the preprint server for biology · Boldridge MA et al.
Prodh2 inhibition alleviates muscle atrophy and restores strength in COPD mice
TNF-alpha triggers a mitochondrial immune pathway via Prodh2 that damages myoblasts, while silencing the enzyme restores muscle strength in mice.
Aging cell · Chen G et al.
Depp1 drives muscle loss under fasting and low oxygen in mice
The study reveals that the protein localizes to mitochondria to regulate autophagy and mitochondrial degradation during nutrient and oxygen limitation.
bioRxiv · Qayyum S et al.
Deleting liver growth hormone receptors accelerates aging phenotypes and shortens lifespan in mice
The loss of hepatic growth hormone signaling disrupts lipid metabolism and causes mitochondrial damage that can be counteracted by inhibiting PDK4.
Aging cell · Yang K et al.